Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma.
about
Splenectomy for people with thalassaemia major and intermediaSplenectomy for people with thalassaemia major or intermediaHemostatic abnormalities in uncomplicated babesiosis (Babesia rossi) in dogs.Association of coagulation activation with clinical complications in sickle cell diseaseElevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.Hypercoagulability in congenital haemolytic anaemiasCoagulation activation in sickle cell trait: an exploratory studyMonitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences.Microparticles in stored red blood cells: submicron clotting bombs?Coagulopathy in Beta-thalassemia: current understanding and future perspectives.The surgeon and the patient with β-thalassaemia intermedia.Thalassemia and venous thromboembolism.Thrombosis in thalassemia: why are we so concerned?Hypercoagulability in β-thalassemia: a status quo.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience.Alloimmunization to Red Cells and the Association of Alloantibodies Formation with Splenectomy Among Transfusion-Dependent β-Thalassemia Major/HbE Patients.Intracranial Blood Flow Velocity in Patients with β-Thalassemia Intermedia Using Transcranial Doppler Sonography: A Case-Control Study.Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.Hypercoagulability and thrombotic complications in hemolytic anemias.Red cell alloimmunization in a diverse population of transfused patients with thalassaemia.Global coagulation in myeloproliferative neoplasms.Using antifibrinolytics in the peripartum period - concern for a hypercoagulable effect?Platelet proteomics in thalassemia: Factors responsible for hypercoagulation.
P2860
Q24202998-314A9275-F34F-407E-B3DE-6FB827368721Q26471468-C05C78AE-C956-41BC-B527-FEB4C643C7BCQ33404618-47BA124E-EE19-4393-B777-5CC957DB416CQ34130633-CE82CAE2-495F-4F59-A34D-05B5D35BE149Q35743427-37F1C46A-2550-45C1-BFAB-8BEE49DED254Q36393525-3AB3FD91-62CD-4C08-8AEC-A92AAA16601DQ36661960-494DF13A-7149-4B32-A95D-2266FD67B840Q37646648-515F6645-1376-44F8-97D7-8FF7DF802F36Q37770410-BB14EB30-8B6E-401D-9950-09233132D339Q37854470-ADCC7CE3-0D1F-4F72-9DDB-A80652A10B12Q37863611-EE180223-2B84-4B6F-A526-373763377F7FQ37895481-B3B916A4-2001-4FD1-84BF-684A46C515D2Q37930653-A01DBC7C-E107-4AFC-A065-261E8F376515Q38059250-120CC797-FBAF-42A4-82BD-9C420701296FQ38261764-4AACAD2C-002B-4CC8-9AE6-D0865154734AQ38778713-91F32B4E-6320-4A34-8CAC-0E72962A5364Q39516644-F0D4FF3E-1B9B-4C6F-9FD9-9EA05F41F66BQ40253377-F2E464FF-E0B0-41C2-9652-692BA6339497Q41547084-91827B87-019C-4BB9-AB97-188AF2E0F32BQ41576877-AD2F6A88-00DE-4B87-9080-22648B6BA510Q42604563-55EBA57E-00B8-4009-864E-B4AAC14FAD7BQ44539191-84960878-F497-4173-B924-D609314B3707Q45723065-41C178A1-73C1-4587-9837-C7ADF20FDDC3Q50793083-A1566D06-BA41-4968-88E1-BD518094A42DQ52914539-86FAB264-5AC7-42C6-A64E-E134B6C57D54
P2860
Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypercoagulability in splenect ...... ation in platelet-poor plasma.
@en
Hypercoagulability in splenect ...... ation in platelet-poor plasma.
@nl
type
label
Hypercoagulability in splenect ...... ation in platelet-poor plasma.
@en
Hypercoagulability in splenect ...... ation in platelet-poor plasma.
@nl
prefLabel
Hypercoagulability in splenect ...... ation in platelet-poor plasma.
@en
Hypercoagulability in splenect ...... ation in platelet-poor plasma.
@nl
P2093
P2860
P1433
P1476
Hypercoagulability in splenect ...... ation in platelet-poor plasma.
@en
P2093
Alessia Marcon
Armando Tripodi
Lidia Padovan
Maria Domenica Cappellini
Maria Rosaria Fasulo
Veena Chantarangkul
P2860
P304
P356
10.3324/HAEMATOL.2009.010546
P577
2009-07-31T00:00:00Z